Form 4 Tracker
Kiniksa Pharmaceuticals International, plc
KNSA

43 insider filings · Latest: Sep 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 20, 2025Oct 20 9:49 PMPatel Sanj K
Proposed Sale
257,969$38.90$10.0M—

View →

Oct 20, 2025Oct 20 9:48 PMMegna Michael R
Proposed Sale
50,490$38.88$2.0M—

View →

Oct 14, 2025Oct 14 8:52 PMTessari Eben
Proposed Sale
12,368$37.66$465.8K—

View →

Sep 29, 2025Sep 29 9:24 PMTessari Eben
Proposed Sale
42,000$38.33$1.6M—

View →

Sep 15, 2025Sep 15 9:20 PMTessari Eben
Proposed Sale
16,400$36.46$598.0K—

View →

Sep 5, 2025Sep 5 8:39 PMTessari Eben
Proposed Sale
13,389$35.66$477.5K—

View →

Sep 4, 2025Sep 4 8:52 PMTessari Eben
Proposed Sale
85,271$35.52$3.0M—

View →

Sep 4, 2025Sep 4 8:51 PMMoat Ross
Proposed Sale
3,523$35.31$124.4K—

View →

Sep 3, 2025Sep 3 8:56 PMTessari Eben
Proposed Sale
15,091$35.50$535.8K—

View →

Sep 3, 2025Sep 3 8:16 PMMegna Michael R
Proposed Sale
11,000$34.84$383.2K—

View →

Aug 18, 2025Aug 18 9:13 PMTessari Eben
Proposed Sale
16,200$33.77$547.1K—

View →

Aug 14, 2025Aug 14 8:36 PMMalley Thomas
Proposed Sale
78,233$33.09$2.6M—

View →

Aug 13, 2025Aug 13 8:24 PMMalley Thomas
Proposed Sale
50,129$33.32$1.7M—

View →

Aug 12, 2025Aug 12 8:54 PMMalley Thomas
Proposed Sale
49,407$32.40$1.6M—

View →

Aug 6, 2025Aug 6 9:37 PMPaolini John F.
Proposed Sale
29,325$32.55$954.5K—

View →

Aug 5, 2025Aug 5 9:23 PMTessari Eben
Proposed Sale
138,614$33.20$4.6M—

View →

Aug 4, 2025Aug 4 8:09 PMRagosa Mark
Proposed Sale
18,889$32.89$621.3K—

View →

Aug 4, 2025Aug 4 8:09 PMMegna Michael R
Proposed Sale
17,000$32.35$549.9K—

View →

Jul 30, 2025Jul 30 8:06 PMKIMBERLY J. POPOVITS
Proposed Sale
64,508$29.90$1.9M—

View →

Jul 14, 2025Jul 14 9:04 PMTessari Eben
Proposed Sale
18,900$28.72$542.9K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 29, 2026Jun 2 8:48 PMTracey L MccainDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:48 PMTracey L MccainDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:46 PMThomas MalleyDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:46 PMThomas MalleyDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:44 PMRichard S LevyDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:44 PMRichard S LevyDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:42 PMBradley G ColeDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:42 PMBradley G ColeDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:30 PMBAKER BROS. ADVISORS LPDirector
Grant/Award
72,948$48.3836,474(I)

View →

May 1, 2026May 5 8:54 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
58,424$10.3629,670(D)

View →

May 1, 2026May 1 8:32 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
48,565$30.930(D)

View →

Apr 30, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
2,141$30.9348,565(D)

View →

Apr 29, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
22,544$30.9350,706(D)

View →

Apr 28, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
483,654$30.9373,250(D)

View →

Apr 28, 2026Apr 29 8:46 PMBarry D QuartDirector
Option Exercise
13,099$14.3313,237(D)

View →

Apr 7, 2026Apr 8 8:45 PMEben TessariCHIEF STRATEGY OFFICER
Option Exercise
2,726—0(D)

View →

Apr 7, 2026Apr 8 8:44 PMMark RagosaCHIEF FINANCIAL OFFICER
Option Exercise
2,694—0(D)

View →

Apr 7, 2026Apr 8 8:43 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
9,991—0(D)

View →

Apr 6, 2026Apr 8 8:43 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
7,278$10.36431,904(D)

View →

Apr 7, 2026Apr 8 8:41 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
2,497—0(D)

View →